Compare KRYS & EMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | KRYS | EMN |
|---|---|---|
| Founded | 2015 | 1920 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Major Chemicals |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.8B | 7.1B |
| IPO Year | 2017 | 1993 |
| Metric | KRYS | EMN |
|---|---|---|
| Price | $279.67 | $78.87 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 11 | 14 |
| Target Price | ★ $257.45 | $78.21 |
| AVG Volume (30 Days) | 249.5K | ★ 2.0M |
| Earning Date | 02-17-2026 | 01-29-2026 |
| Dividend Yield | N/A | ★ 4.20% |
| EPS Growth | ★ 275.72 | N/A |
| EPS | ★ 6.66 | 4.10 |
| Revenue | $373,164,000.00 | ★ $8,752,000,000.00 |
| Revenue This Year | $36.10 | $1.78 |
| Revenue Next Year | $42.21 | $3.35 |
| P/E Ratio | $41.50 | ★ $19.53 |
| Revenue Growth | ★ 54.51 | N/A |
| 52 Week Low | $122.80 | $56.11 |
| 52 Week High | $295.98 | $103.82 |
| Indicator | KRYS | EMN |
|---|---|---|
| Relative Strength Index (RSI) | 55.88 | 65.80 |
| Support Level | $264.85 | $79.27 |
| Resistance Level | $280.00 | $83.47 |
| Average True Range (ATR) | 11.47 | 2.98 |
| MACD | -1.66 | 0.41 |
| Stochastic Oscillator | 49.97 | 70.18 |
Krystal Biotech Inc is engaged in the healthcare sector in the United States. It is focused on the development of easy-to-use, redosable gene therapies to improve the lives of patients living with debilitating diseases. The company used its proprietary gene therapy platform, STAR-D to develop treatments for rare or orphan dermatological indications caused by the absence of or a mutation in a single gene. It plans to leverage its platform to expand its pipeline to include other dermatological indications in the future. The company has one operating segment, which is the business of developing and commercializing pharmaceutical products.
Established in 1920 to produce chemicals for Eastman Kodak, Eastman Chemical has grown into a global specialty chemical company with manufacturing sites around the world. The company generates the majority of its sales outside of the United States, with a strong presence in Asian markets. During the past several years, Eastman has sold noncore businesses, choosing to focus on higher-margin specialty product offerings.